Fig. 1From: Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancerStudy design: Graphical scheme of patient accrual, follow-up, and biomarker analysis [created with Biorender.com]Back to article page